Literature DB >> 22670134

Rett Syndrome.

E E J Smeets1, K Pelc, B Dan.   

Abstract

Rett syndrome is one of the most common causes of complex disability in girls. It is characterized by early neurological regression that severely affects motor, cognitive and communication skills, by autonomic dysfunction and often a seizure disorder. It is a monogenic X-linked dominant neurodevelopmental disorder related to mutation in MECP2, which encodes the methyl-CpG-binding protein MeCP2. There are several mouse models either based on conditional knocking out of the Mecp2 gene or on a truncating mutation. We discuss the clinical aspects with special emphasis on the behavioral phenotype and we review current perspectives in clinical management alongside with perspectives in altering gene expression.

Entities:  

Year:  2012        PMID: 22670134      PMCID: PMC3366703          DOI: 10.1159/000337637

Source DB:  PubMed          Journal:  Mol Syndromol        ISSN: 1661-8769


  82 in total

1.  Autonomic nervous system dysregulation: breathing and heart rate perturbation during wakefulness in young girls with Rett syndrome.

Authors:  Debra E Weese-Mayer; Steven P Lieske; Christina M Boothby; Anna S Kenny; Heather L Bennett; Jean M Silvestri; Jan-Marino Ramirez
Journal:  Pediatr Res       Date:  2006-08-28       Impact factor: 3.756

2.  Rett syndrome--an early catecholamine and indolamine deficient disorder?

Authors:  Y Nomura; M Segawa; M Higurashi
Journal:  Brain Dev       Date:  1985       Impact factor: 1.961

3.  The role of different X-inactivation pattern on the variable clinical phenotype with Rett syndrome.

Authors:  T Ishii; Y Makita; A Ogawa; S Amamiya; M Yamamoto; A Miyamoto; J Oki
Journal:  Brain Dev       Date:  2001-12       Impact factor: 1.961

4.  Management of a severe forceful breather with Rett syndrome using carbogen.

Authors:  Eric E J Smeets; Peter O O Julu; Dick van Waardenburg; Ingegerd Witt Engerström; Stig Hansen; Flora Apartopoulos; Leopold M G Curfs; Connie T R M Schrander-Stumpel
Journal:  Brain Dev       Date:  2006-06-09       Impact factor: 1.961

5.  The disease progression of Mecp2 mutant mice is affected by the level of BDNF expression.

Authors:  Qiang Chang; Gargi Khare; Vardhan Dani; Sacha Nelson; Rudolf Jaenisch
Journal:  Neuron       Date:  2006-02-02       Impact factor: 17.173

6.  MECP2 truncating mutations cause histone H4 hyperacetylation in Rett syndrome.

Authors:  M Wan; K Zhao; S S Lee; U Francke
Journal:  Hum Mol Genet       Date:  2001-05-01       Impact factor: 6.150

Review 7.  Neurodevelopmental disorders in males related to the gene causing Rett syndrome in females (MECP2).

Authors:  Ute Moog; Eric E J Smeets; Kees E P van Roozendaal; Sam Schoenmakers; Jos Herbergs; Anneke M J Schoonbrood-Lenssen; Connie T R M Schrander-Stumpel
Journal:  Eur J Paediatr Neurol       Date:  2003       Impact factor: 3.140

8.  Partial reversal of Rett Syndrome-like symptoms in MeCP2 mutant mice.

Authors:  Daniela Tropea; Emanuela Giacometti; Nathan R Wilson; Caroline Beard; Cortina McCurry; Dong Dong Fu; Ruth Flannery; Rudolf Jaenisch; Mriganka Sur
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-10       Impact factor: 11.205

9.  Spectrum and distribution of MECP2 mutations in 424 Rett syndrome patients: a molecular update.

Authors:  C Philippe; L Villard; N De Roux; M Raynaud; J P Bonnefond; L Pasquier; G Lesca; J Mancini; P Jonveaux; A Moncla; J Chelly; T Bienvenu
Journal:  Eur J Med Genet       Date:  2006 Jan-Feb       Impact factor: 2.708

Review 10.  When enough is enough: genetic diseases associated with transcriptional derepression.

Authors:  Davide Gabellini; Michael R Green; Rossella Tupler
Journal:  Curr Opin Genet Dev       Date:  2004-06       Impact factor: 5.578

View more
  22 in total

Review 1.  Genetics, molecular biology, and phenotypes of x-linked epilepsy.

Authors:  Hao Deng; Wen Zheng; Zhi Song
Journal:  Mol Neurobiol       Date:  2013-11-22       Impact factor: 5.590

2.  Treatment of dyssomnias and parasomnias in childhood.

Authors:  Suresh Kotagal
Journal:  Curr Treat Options Neurol       Date:  2012-12       Impact factor: 3.598

3.  Disruption of MBD5 contributes to a spectrum of psychopathology and neurodevelopmental abnormalities.

Authors:  J C Hodge; E Mitchell; V Pillalamarri; T L Toler; F Bartel; H M Kearney; Y S Zou; W H Tan; C Hanscom; S Kirmani; R R Hanson; S A Skinner; R C Rogers; D B Everman; E Boyd; C Tapp; S V Mullegama; D Keelean-Fuller; C M Powell; S H Elsea; C C Morton; J F Gusella; B DuPont; A Chaubey; A E Lin; M E Talkowski
Journal:  Mol Psychiatry       Date:  2013-04-16       Impact factor: 15.992

4.  Clinical presentation of Rett syndrome in relation to quality of life and family functioning.

Authors:  Anna Rozensztrauch; Agnieszka Sebzda; Robert Śmigiel
Journal:  J Int Med Res       Date:  2021-04       Impact factor: 1.671

5.  Phenotypic and molecular convergence of 2q23.1 deletion syndrome with other neurodevelopmental syndromes associated with autism spectrum disorder.

Authors:  Sureni V Mullegama; Joseph T Alaimo; Li Chen; Sarah H Elsea
Journal:  Int J Mol Sci       Date:  2015-04-07       Impact factor: 5.923

6.  Prevalence and onset of comorbidities in the CDKL5 disorder differ from Rett syndrome.

Authors:  Meghana Mangatt; Kingsley Wong; Barbara Anderson; Amy Epstein; Stuart Hodgetts; Helen Leonard; Jenny Downs
Journal:  Orphanet J Rare Dis       Date:  2016-04-14       Impact factor: 4.123

7.  Comparing social reciprocity in preserved speech variant and typical Rett syndrome during the early years of life.

Authors:  Gillian S Townend; Katrin D Bartl-Pokorny; Jeff Sigafoos; Leopold M G Curfs; Sven Bölte; Luise Poustka; Christa Einspieler; Peter B Marschik
Journal:  Res Dev Disabil       Date:  2015-07-07

8.  Synaptic plasticity in mouse models of autism spectrum disorders.

Authors:  Leeyup Chung; Alexandra L Bey; Yong-Hui Jiang
Journal:  Korean J Physiol Pharmacol       Date:  2012-12-10       Impact factor: 2.016

9.  Dysregulation of the long non-coding RNA transcriptome in a Rett syndrome mouse model.

Authors:  Paolo Petazzi; Juan Sandoval; Karolina Szczesna; Olga C Jorge; Laura Roa; Sergi Sayols; Antonio Gomez; Dori Huertas; Manel Esteller
Journal:  RNA Biol       Date:  2013-04-17       Impact factor: 4.652

10.  Vascular dysfunction in a mouse model of Rett syndrome and effects of curcumin treatment.

Authors:  Anna Panighini; Emiliano Duranti; Ferruccio Santini; Margherita Maffei; Tommaso Pizzorusso; Niccola Funel; Stefano Taddei; Nunzia Bernardini; Chiara Ippolito; Agostino Virdis; Mario Costa
Journal:  PLoS One       Date:  2013-05-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.